Genomed (WAR:GEN) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 04, 2026)


WAR:GEN Genomed SA WAR:GEN
74 GF Score
Price zł29.00
GF Value zł37.88
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Genomed Float Percentage Of Total Shares Outstanding?

Genomed WAR:GEN +14.17% 74 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 04, 2026. GuruFocus rates WAR:GEN with a GF Score™ of 74/100 and a GF Value™ of zł37.88 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Genomed's float shares is 0.00 Mil. Genomed's total shares outstanding is 1.32 Mil. Genomed's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Genomed's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Genomed's Institutional Ownership is 0.00%.

WAR:GEN
74GF Score
Genomed SA WAR:GEN
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomed Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Genomed's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1.32
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Genomed (WAR:GEN) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Genomed and its competitors.
Is Genomed's Float Percentage Of Total Shares Outstanding too high?
Genomed's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Genomed has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomed's Float Percentage Of Total Shares Outstanding compare to TMO and DHR?
Genomed's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Diagnostics & Research company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Diagnostics & Research industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Genomed and its competitors. Genomed's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomed stock overvalued right now?
Based on GuruFocus' analysis, Genomed (WAR:GEN) is currently considered Modestly Undervalued. The stock's GF Value™ is zł37.88, compared to a current price of zł29.00 — trading 23.4% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Genomed's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Genomed (WAR:GEN), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomed (WAR:GEN) Overvalued in 2026?

Based on GuruFocus' analysis, Genomed stock appears to be undervalued. The current stock price of zł29.00 is trading 23.4% below its estimated GF Value™ of zł37.88. GuruFocus considers Genomed to be Modestly Undervalued.

Key valuation signals for WAR:GEN:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: zł37.88 vs. price of zł29.00 (23.4% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the WAR:GEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomed Business Description

Address Ulica Ponczowa 12, Warszawa, POL, 02-971
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.
74GF Score

Get the complete analysis for WAR:GEN

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł29.00
Price
zł37.88
GF Value